Debt-to-equity of AGIOS PHARMACEUTICALS, INC. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AGIOS PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • AGIOS PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 7%, a 45% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 7% -6% -45% 30 Sep 2025
Q2 2025 8% -7% -47% 30 Jun 2025
Q1 2025 9% -5% -34% 31 Mar 2025
Q4 2024 11% -2% -15% 31 Dec 2024
Q3 2024 13% +1% +7.1% 30 Sep 2024
Q2 2024 15% +3% +23% 30 Jun 2024
Q1 2024 14% +2% +17% 31 Mar 2024
Q4 2023 13% +1% +11% 31 Dec 2023
Q3 2023 12% +1% +8.7% 30 Sep 2023
Q2 2023 12% +1% +11% 30 Jun 2023
Q1 2023 12% +2% +16% 31 Mar 2023
Q4 2022 12% +2% +23% 31 Dec 2022
Q3 2022 11% -5% -30% 30 Sep 2022
Q2 2022 11% -14% -56% 30 Jun 2022
Q1 2022 10% -30% -74% 31 Mar 2022
Q4 2021 10% -62% -87% 31 Dec 2021
Q3 2021 16% -39% -71% 30 Sep 2021
Q2 2021 25% -23% -48% 30 Jun 2021
Q1 2021 40% -1% -3.2% 31 Mar 2021
Q4 2020 71% +29% +68% 31 Dec 2020
Q3 2020 55% +17% +44% 30 Sep 2020
Q2 2020 48% +18% +58% 30 Jun 2020
Q1 2020 41% +16% +66% 31 Mar 2020
Q4 2019 43% +21% +94% 31 Dec 2019
Q3 2019 38% +11% +42% 30 Sep 2019
Q2 2019 30% -2% -7.2% 30 Jun 2019
Q1 2019 25% -16% -40% 31 Mar 2019
Q4 2018 22% 31 Dec 2018
Q3 2018 27% 30 Sep 2018
Q2 2018 33% 30 Jun 2018
Q1 2018 41% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.